Journal
DIABETES CARE
Volume 33, Issue 7, Pages 1647-1651Publisher
AMER DIABETES ASSOC
DOI: 10.2337/dc09-2208
Keywords
-
Categories
Funding
- NIHR Biomedical Research Centre
- Pfizer, Inc., New York
- Servier Research Group, Paris, France
- National Institute for Health Research [NF-SI-0508-10116] Funding Source: researchfish
Ask authors/readers for more resources
OBJECTIVE - To evaluate whether in hypertensive patients the risk of cardiovascular disease is greater in association with the metabolic syndrome (MetS) or the sum of its individual components. RESEARCH DESIGN AND METHODS - Cox regression analysis models were developed to assess the influence of age, sex, ethnicity, and the individual components of MetS on risk associated with the MetS (using several definitions) of coronary outcomes, stroke, and all-cause mortality. RESULTS - MetS was significantly associated with coronary outcomes, stroke, and all-cause mortality after adjusting for age, sex, and ethnicity. However, when the model was further adjusted for the individual components, MetS was associated with significantly increased risk of stroke (hazard ratio 1.34 [95% Cl 1.07-1.68]) and all-cause mortality (1.35 [1.16-1.58]) but not coronary outcomes (fatal coronary heart disease plus nonfatal myocardial infarction 1.16 [0.95-1.43] and total coronary events 1.06 [0.91-1.24]). CONCLUSIONS - MetS, independent of its individual components, is associated with increased risk of stroke and all-cause mortality but not coronary outcomes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available